Back
Back
-
Regulations & Services of PMDAInformation about Approved Products in JapanInternational ActivitiesSafety InformationAdvanced Efforts
-
Information for approved products in JapanSafety information
-
Development of Drugs, Medical devices, Regenerative medicines and in Vitro diagnosticsInformation for approved products in JapanRegulatory science
-
Regulations and services of PMDAInformation for approved products in JapanProcedures in JapanAdvanced efforts
Back
-
Regulations and Services of PMDAInformation for apporoved products in JapanSafety informationProcedures in Japan
-
Regulations and Services of PMDAInformation for apporoved products in JapanSafety informationProcedures in Japan
-
Reviews and Related ServicesRegulatory ProceduresPost-marketing Safety Measures
-
Reviews and Related ServicesPost-marketing Safety
Measures
- Home
- Regulatory Science/The Science Board/Standard Development
- Standard Development
- Japanese Pharmacopoeia
- Public comments
- Japanese Pharmacopoeia
- Public comments (Japanese Pharmacopoeia) (Fiscal year 2022)
Regulatory Science/The Science Board/Standard Development